Adderall and Hair loss - a phase IV clinical study of FDA data
Summary:
Hair loss is reported as a side effect among people who take Adderall (amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate), especially for people who are female, 40-49 old, have been taking the drug for 10+ years also take Xyrem, and have Multiple sclerosis.
The phase IV clinical study analyzes which people have Hair loss when taking Adderall. It is created by eHealthMe based on reports of 50,493 people who have side effects when taking Adderall from the FDA, and is updated regularly.
What is Adderall?
Adderall has active ingredients of amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 64,225 Adderall users. Check the latest studies of Adderall.
What is Hair loss?
Hair loss is found to be associated with 2,411 drugs and 3,514 conditions by eHealthMe. Check the latest studies of Hair loss.
50,493 people reported to have side effects when taking Adderall.
Among them, 680 people (1.35%) have Hair loss.
Among these 680 people:
How long have people been on Adderall when they have Hair loss? *
What is the gender of people who have Hair loss when taking Adderall? *
What is the age of people who have Hair loss when taking Adderall? *
What are other drugs people take besides Adderall? *
What are other side effects people have besides Hair loss? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Adderall and have Hair loss?
- Check whether Hair loss is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Adderall:
- Adderall (64,225 reports)
Hair loss treatments and more:
- Hair loss (271,201 reports)
How severe was Hair loss and when was it recovered:
Expand to all the drugs that have ingredients of amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Adderall:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Hair loss:
- Hair loss (2,411 drugs)
Browse all the conditions that are associated with Hair loss:
- Hair loss (3,514 conditions)
Related publications that referenced our studies
- Lindsey SF, Tosti A, "Hair loss induced by tumor necrosis factor alpha inhibitors", J Clin Investigat Dermatol, 2015 Jan .
- Lindsey SF, Tosti A, "Hair loss induced by tumor necrosis factor alpha inhibitors", J Clin Investigat Dermatol, 2015 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate (the active ingredients of Adderall) and Adderall (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Kerlone cause Renal Failure Aggravated? - now
- Blood Bilirubin Increased and drugs of ingredients of pseudoephedrine hydrochloride - 7 seconds ago
- Bleeding Into The Skin in Vitamin D, how severe and when it was recovered? - 30 seconds ago
- Jardiance and Plavix drug interactions for men aged 60+ - 32 seconds ago
- Could Zocor cause General Physical Health Deterioration? - 44 seconds ago
- Drug interactions of Bumetanide and Jantoven - 54 seconds ago
- Cymbalta and Hypokalemic Syndrome for Women aged 60+ - 59 seconds ago
- Cymbalta and Hypokalaemic Syndrome for Women aged 60+ - a minute ago
- Cymbalta and Hypopotassemia for Women aged 60+ - a minute ago
- Cymbalta and Hypokalaemia for Women aged 60+ - a minute ago